‘Repurposed’ anti-parasite drug shows promise as new TB treatment: UBC research

(University of British Columbia) A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis, according to new research from University of British Columbia microbiologists.The findings, published online this week in the journal Antimicrobial Agents and Chemotherapy, are based on in vitro tests of the avermectin family of drugs. Discovered nearly 40 years ago, the drugs are commonly used in the developing world to eliminate the parasitic worms that cause river blindness and elephantiasis. (Source: EurekAlert! – Infectious and Emerging Diseases)
Source: Blindness